Related Experiment Video
Updated: May 16, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Low blood counts: immune mediated, idiopathic, or myelodysplasia
1Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria. peter.valent@meduniwien.ac.at
Insights
Diagnosing mild cytopenias can be challenging, especially in early myelodysplastic syndrome (MDS). This review outlines diagnostic approaches, highlighting circulating progenitor cells and flow cytometry as key indicators for unexplained cytopenias.
Area of Science:
- Hematology
- Clinical Diagnostics
Background:
- Cytopenias are traditionally classified, but mild cases present diagnostic challenges.
- Chronic mild cytopenias often have nonspecific laboratory and clinical signs, complicating diagnosis.
- Distinguishing early myelodysplastic syndrome (MDS) from other causes of mild cytopenia is difficult.
Purpose of the Study:
- To provide an overview of diagnostic approaches for patients with mild unexplained cytopenias.
- To highlight key parameters for differentiating early MDS from other cytopenic conditions.
- To offer diagnostic algorithms for challenging cytopenia cases.
Main Methods:
- Review of diagnostic criteria and approaches for mild cytopenias.
- Emphasis on peripheral blood parameters, specifically circulating colony-forming progenitor cells.
- Inclusion of flow cytometric and molecular investigations for clonal vs. reactive conditions.
Main Results:
- Circulating colony-forming progenitor cell numbers are a reliable peripheral blood parameter for early MDS detection.
- Flow cytometry and molecular studies can aid in distinguishing clonal from reactive causes.
- Traditional diagnostic criteria are often insufficient for mild or chronic cytopenias.
Conclusions:
- Mild unexplained cytopenias require specialized diagnostic strategies beyond standard classifications.
- Early identification of MDS in mild cytopenias is crucial and can be aided by progenitor cell counts.
- Comprehensive diagnostic algorithms incorporating advanced techniques are essential for accurate diagnosis.
Abstract:
Traditionally, cytopenias are classified as deficiency mediated, immune mediated, BM failure induced, renal, or idiopathic, with the latter including the so-called idiopathic cytopenias of undetermined significance (ICUS). Clinical findings, symptoms, blood counts, BM findings, and other laboratory parameters are usually sufficient to reveal the type and cause of a marked cytopenia. However, in patients with chronic mild cytopenia, it may be a challenge for the physician to establish a correct diagnosis. In such patients, laboratory features and findings often reflect a diagnostic interface, so that criteria that are otherwise robust may hardly be applicable or are not helpful. Even if the BM is examined, the diagnosis often remains uncertain in these patients. In addition, more than one potential cause of cytopenia may be present, especially in the elderly. A myelodysplastic syndrome (MDS) or another BM disorder, but also an overt autoimmune or other inflammatory disease, may develop during follow-up in these patients. A key problem is that in an early phase of MDS, most laboratory and clinical signs are "nonspecific." One of the very few reliable peripheral blood parameters distinguishing between an early or "pre-phase" of MDS and most other causes of a mild cytopenia are the numbers of circulating colony-forming progenitor cells. In addition, flow cytometric and molecular investigations may sometimes assist in the delineation between clonal and reactive conditions underlying mild cytopenias. This review provides an overview of diagnostic approaches and algorithms for patients with mild unexplained cytopenia(s).
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
